TWI368617B - Thiophene compounds and thrombopoietin receptor activators - Google Patents
Thiophene compounds and thrombopoietin receptor activatorsInfo
- Publication number
- TWI368617B TWI368617B TW095125693A TW95125693A TWI368617B TW I368617 B TWI368617 B TW I368617B TW 095125693 A TW095125693 A TW 095125693A TW 95125693 A TW95125693 A TW 95125693A TW I368617 B TWI368617 B TW I368617B
- Authority
- TW
- Taiwan
- Prior art keywords
- thiophene compounds
- thrombopoietin receptor
- receptor activators
- activators
- thrombopoietin
- Prior art date
Links
- 102000005763 Thrombopoietin Receptors Human genes 0.000 title 1
- 108010070774 Thrombopoietin Receptors Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 150000003577 thiophenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005206822 | 2005-07-15 | ||
| JP2005206823 | 2005-07-15 | ||
| JP2006083770 | 2006-03-24 | ||
| JP2006083771 | 2006-03-24 | ||
| JP2006115569 | 2006-04-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200728298A TW200728298A (en) | 2007-08-01 |
| TWI368617B true TWI368617B (en) | 2012-07-21 |
Family
ID=37243773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095125693A TWI368617B (en) | 2005-07-15 | 2006-07-13 | Thiophene compounds and thrombopoietin receptor activators |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7968542B2 (zh) |
| EP (1) | EP1904472A1 (zh) |
| JP (1) | JP5071375B2 (zh) |
| KR (1) | KR101343686B1 (zh) |
| AU (1) | AU2006270801B2 (zh) |
| CA (1) | CA2609319C (zh) |
| IL (1) | IL188701A (zh) |
| NO (1) | NO20075734L (zh) |
| NZ (1) | NZ563202A (zh) |
| TW (1) | TWI368617B (zh) |
| WO (1) | WO2007010954A1 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA82695C2 (uk) * | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
| US7879318B2 (en) * | 2006-01-23 | 2011-02-01 | Mcw Research Foundation, Inc. | Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand |
| EP2025671A4 (en) * | 2006-06-07 | 2011-04-06 | Nissan Chemical Ind Ltd | NITROGENIC HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR |
| EP2218716B1 (en) * | 2007-12-06 | 2016-11-16 | Nissan Chemical Industries, Ltd. | Method for amplifying hematopoietic stem cells using heterocyclic compound |
| TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| EP2439204B1 (en) * | 2009-06-04 | 2017-01-04 | Nissan Chemical Industries, Ltd. | Heterocyclic compound and hematopoietic stem cell amplifier |
| US8618307B2 (en) | 2009-09-16 | 2013-12-31 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2011049213A1 (ja) * | 2009-10-23 | 2011-04-28 | 日産化学工業株式会社 | 縮環へテロ環化合物及びトロンボポエチンレセプター活性化剤 |
| EP2723717A2 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| MX2013015058A (es) | 2011-06-24 | 2014-01-20 | Amgen Inc | Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos. |
| US20140227780A1 (en) | 2011-10-03 | 2014-08-14 | Nissan Chemical Industries, Ltd. | Method for producing megakaryocytes and/or platelets from pluripotent stem cells |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| TWI848953B (zh) | 2018-06-09 | 2024-07-21 | 德商百靈佳殷格翰國際股份有限公司 | 針對癌症治療之多特異性結合蛋白 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040189A1 (en) | 1995-06-07 | 1996-12-19 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| ES2303338T3 (es) | 1995-06-07 | 2008-08-01 | Glaxo Group Limited | Peptidos y compuestos que se unen a un receptor de trombopoyetina. |
| JPH1072492A (ja) | 1996-09-02 | 1998-03-17 | Hokuriku Seiyaku Co Ltd | ペプチド化合物 |
| JPH111477A (ja) | 1997-06-12 | 1999-01-06 | Hokuriku Seiyaku Co Ltd | １，４−ベンゾジアゼピン誘導体及びその用途 |
| AU9265698A (en) | 1997-09-02 | 1999-03-22 | Boehringer Mannheim Gmbh | Mpl-receptor ligands, process for their preparation, medicaments containing themand their use for the treatment and prevention of thrombocytopaenia and anaemia |
| JPH11152276A (ja) | 1997-11-20 | 1999-06-08 | Hokuriku Seiyaku Co Ltd | ベンゾジアゼピン誘導体 |
| GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
| JP2002543126A (ja) | 1999-05-03 | 2002-12-17 | スミスクライン・ビーチャム・コーポレイション | Ｃｘｃｒ−４受容体アンタゴニスト−トロンボポエチン模倣物 |
| US7026334B1 (en) | 1999-07-26 | 2006-04-11 | Shionogi & Co., Ltd. | Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| ES2256038T3 (es) | 1999-09-10 | 2006-07-16 | Smithkline Beecham Corporation | Mimeticos de trombopoyetina. |
| AU771460B2 (en) | 1999-09-24 | 2004-03-25 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| JP2001097948A (ja) | 1999-09-30 | 2001-04-10 | Torii Yakuhin Kk | トロンボポエチン受容体に親和性を有する化合物 |
| JP2003513965A (ja) | 1999-11-05 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | セミカルバゾン誘導体およびそれらのトロンボポエチン模倣物としての使用 |
| ATE344031T1 (de) | 1999-12-06 | 2006-11-15 | Smithkline Beecham Corp | Thrombopoietin-mimetika |
| TWI284639B (en) | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
| CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| EP1349613A4 (en) | 2000-12-19 | 2005-09-21 | Smithkline Beecham Corp | MIMETICS OF THROMBOPOIETINE |
| MXPA03006510A (es) | 2001-01-26 | 2003-10-15 | Shionogi & Co | Compuestos halogenados que muestran agonismo del receptor de trombopoyetina. |
| EP1361220A4 (en) | 2001-01-26 | 2005-09-07 | Shionogi & Co | CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM |
| US20040077697A1 (en) | 2001-02-02 | 2004-04-22 | Hiroyuki Koshio | 2-Acylaminothiazole derivative or its salt |
| WO2002085343A1 (en) | 2001-03-01 | 2002-10-31 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| CN1319967C (zh) | 2002-01-18 | 2007-06-06 | 安斯泰来制药有限公司 | 2－酰基氨基噻唑衍生物或其盐 |
| JP2003238565A (ja) | 2002-02-19 | 2003-08-27 | Japan Tobacco Inc | 縮合環化合物及びそれら化合物を含んでなる血球増多薬 |
| TWI324593B (en) * | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
| UA82695C2 (uk) | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
| TWI399368B (zh) * | 2004-12-14 | 2013-06-21 | Nissan Chemical Ind Ltd | Amide compounds and thrombopoietin receptor activators |
-
2006
- 2006-07-13 AU AU2006270801A patent/AU2006270801B2/en not_active Ceased
- 2006-07-13 JP JP2008502169A patent/JP5071375B2/ja not_active Expired - Fee Related
- 2006-07-13 EP EP06781284A patent/EP1904472A1/en not_active Withdrawn
- 2006-07-13 TW TW095125693A patent/TWI368617B/zh not_active IP Right Cessation
- 2006-07-13 NZ NZ563202A patent/NZ563202A/en not_active IP Right Cessation
- 2006-07-13 CA CA2609319A patent/CA2609319C/en not_active Expired - Fee Related
- 2006-07-13 US US11/994,502 patent/US7968542B2/en not_active Expired - Fee Related
- 2006-07-13 WO PCT/JP2006/314317 patent/WO2007010954A1/en not_active Ceased
-
2007
- 2007-11-09 NO NO20075734A patent/NO20075734L/no not_active Application Discontinuation
-
2008
- 2008-01-10 IL IL188701A patent/IL188701A/en not_active IP Right Cessation
- 2008-01-15 KR KR1020087001205A patent/KR101343686B1/ko not_active Expired - Fee Related
-
2010
- 2010-11-29 US US12/955,477 patent/US20110092496A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR101343686B1 (ko) | 2013-12-20 |
| IL188701A0 (en) | 2008-08-07 |
| TW200728298A (en) | 2007-08-01 |
| AU2006270801A1 (en) | 2007-01-25 |
| NO20075734L (no) | 2008-02-04 |
| CA2609319A1 (en) | 2007-01-25 |
| WO2007010954A1 (en) | 2007-01-25 |
| US7968542B2 (en) | 2011-06-28 |
| CA2609319C (en) | 2014-02-04 |
| IL188701A (en) | 2013-08-29 |
| NZ563202A (en) | 2011-02-25 |
| EP1904472A1 (en) | 2008-04-02 |
| KR20080031903A (ko) | 2008-04-11 |
| US20110092496A1 (en) | 2011-04-21 |
| US20090118500A1 (en) | 2009-05-07 |
| AU2006270801B2 (en) | 2011-12-22 |
| JP2009501131A (ja) | 2009-01-15 |
| JP5071375B2 (ja) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188701A0 (en) | Thiophene compounds and thrombopoietin receptor activators | |
| IL244442B (en) | Compounds of converted acylanilides and their use | |
| EP1744757A4 (en) | IMPROVED ENHANCED COMPOSITION | |
| IL192395A0 (en) | Modified lysine-mimetic compounds | |
| IL183647A0 (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators | |
| GB0521796D0 (en) | Gtgvr software application | |
| SG131860A1 (en) | Inorganic composition | |
| ZA200708451B (en) | Packaging materials | |
| IL185223A0 (en) | Compounds and uses thereof | |
| ZA200700688B (en) | Tissue-adhesive materials | |
| EP1777435A4 (en) | CUSHIONING MATERIAL | |
| GB0425288D0 (en) | Packaging materials | |
| GB0607000D0 (en) | Handling jitter | |
| EP1947101A4 (en) | HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | |
| ZA200710465B (en) | Thiophene compounds and thrombopoletin receptor activators | |
| HK1117142A (zh) | 噻吩化合物和血小板生成素受体活化剂 | |
| GB0520639D0 (en) | An improved spreader | |
| GB0516946D0 (en) | Receptor | |
| EG26193A (en) | Air flow oscillator | |
| GB0511321D0 (en) | Inorganic compounds | |
| ZA200704979B (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators | |
| AU3617P (en) | BRA01 Cordyline fruticosa | |
| GB0408765D0 (en) | Double spreader | |
| PL375573A3 (pl) | Siatka okładziny górniczej | |
| GB0521272D0 (en) | Compounds and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |